NCT03514381View on ClinicalTrials.gov

Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

May 18, 2018

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Patients starting a treatment with Doxorubicin and Ifosfamide

"9 blood samples will be collected at each Cycle:~* Cycle 1 (Day 1-Day 2-Day 3)~* Cycle 2 (Day 1-Day 2-Day 3)"

Trial Locations (3)

31059

Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse

33076

Institut Bergonie, Bordeaux

34298

Institut Regional Du Cancer de Montpellier (Icm), Montpellier

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT03514381 - Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter